Ausanil Overview

  • Founded
  • 2012
  • Status
  • Out of Business
  • Employees
  • 2
  • Latest Deal Type
  • Out of Business

Ausanil General Information


Developer of medicines designed to treat headaches and migraine. The company's medicines along with nasal sprays offers to treat severe headaches and migraine in human brain, enabling patients to get relief from related pains and other inconvenience without any side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 68 East 131st Street
  • Suite 307
  • New York, NY 10037
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ausanil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 00.000 Completed Out of Business
2. Seed Round 01-Aug-2014 00.000 00.000 Completed Generating Revenue
1. Angel (individual) 28-Jun-2013 $1.15M $1.15M Completed Generating Revenue
To view Ausanil’s complete valuation and funding history, request access »

Ausanil Executive Team (2)

Name Title Board Seat Contact Info
Anjan Chatterjee MD Co-Founder and Chief Executive Officer
You’re viewing 1 of 2 executive team members. Get the full list »

Ausanil Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial